By DENISE GRADY
The F.D.A. made the product review a priority, citing shortages that occurred in the wake of several recalls of drugs that were found to contain potentially cancer-causing chemicals.
Published: March 11, 2019 at 08:00PM
from NYT Health https://ift.tt/2XRWcE2
via IFTTT
from WordPress https://ift.tt/2UAxxC6
via IFTTT
No comments:
Post a Comment